SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001607062-14-000203
Filing Date
2014-12-18
Accepted
2014-12-17 20:08:15
Documents
12
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K rgbp20149030form10k.htm 10-K 617780
2 SUBLEASE AGREEMENT rgbp20149030form10kex10_21.htm EX-10.21 7691
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER rgbp20149030form10kex31_1.htm EX-31.1 9999
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER rgbp20149030form10kex31_2.htm EX-31.2 10153
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER rgbp20149030form10kex32_1.htm EX-32.1 6565
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER rgbp20149030form10kex32_2.htm EX-32.2 5317
  Complete submission text file 0001607062-14-000203.txt   2230692

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE rgbp-20140930.xml EX-101.INS 188812
8 XBRL SCHEMA FILE rgbp-20140930.xsd EX-101.SCH 19882
9 XBRL CALCULATION FILE rgbp-20140930_cal.xml EX-101.CAL 24058
10 XBRL DEFINITION FILE rgbp-20140930_def.xml EX-101.DEF 22040
11 XBRL LABEL FILE rgbp-20140930_lab.xml EX-101.LAB 116882
12 XBRL PRESENTATION FILE rgbp-20140930_pre.xml EX-101.PRE 92919
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 333-191725 | Film No.: 141293982
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences